Study Group: Tricyclic Antipsychotic Prescribers: Psychiatrists (?)
Council Members in this Study Group: 12
Request a survey with this Study Group
Leading Experts in this Study Group
Founder and Director
Institute for Integrative Psychiatry
Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between medical and psychiatric conditions. Prior to that,...
Louis Sanfilippo, MDPresident
LCS Group, LLC
Louis Sanfilippo, MD, is President of the LCS Group, since April 2008, a consulting firm focused on pharmaceutical development and market strategy. He is an Assistant Clinical Professor of Psychiatry at Yale School of Medicine and in private practice. Dr. Sanfilippo has served management and scientific...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Psychiatrists | 1458 |
| Psychiatrists (US) | 1116 |
| Physicians who Treat Schizophrenia (US) | 344 |
| Clozaril Prescribers (US) | 41 |
| Seroquel Prescribers forSchizophrenia (US) | 110 |
| Effexor XR Prescribers (US) | 139 |
| Physicians who Treat Depression (US) | 381 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Astra Zeneca is pursuing important medical and, of course, commercial goals by seeking the expanded clinical indications of major depression and generalized anxiety disorder for Seroquel XR, heir to blockbuster Seroquel (quetiapine). This latest EU submission culminates regulatory submissions...
“Personalized medical diagnositics” looks to be evolving as a high impact area in neuropsychiatric drug development. Such ‘genetic biomarker’ platforms, based on either pharmacogenetic profiles coming from DNA blueprints or gene products from a simple blood draw, aim to identify patients who are...
‘One drug, many uses’ can make lots of sense clinically and commercially. Seeking additional FDA indications for a specific drug has obvious business benefits: greater revenue stream, improved branding, potentially longer market exclusivity, greater franchising potential of the drug...
Lundbeck has now disclosed the mechanism of action of its “mixed serotonin modulator and stimulator,” albeit buried in a first quarter report. Data on LuAA21004, Lundbeck’s lead antidepressant jointly in development with Takeda, was released at the Scandinavian College of Neuro-Psychopharmacology...
It’s not clear just how BrainCells’ BCI-540 works but the company claims the drug acts by way of promoting neurogenesis without an effect on serotonin neurotransmission. While SSRI’s also promote neurogenesis, a downstream effect believed to favorably impact mood and anxiety, they obviously...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Consultancy, Pharma-Focused
- Government/Military Hospital or Clinic
- Non-profit organization
- Office Based Private Practice or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Director
- President
- Physician - Division Head
- Owner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms